Miura H, Miyazaki T, Kuroda M, Oka T, Machinami R, Kodama T, Shibuya M, Makuuchi M, Yazaki Y, Ohnishi S
Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.
J Hepatol. 1997 Nov;27(5):854-61. doi: 10.1016/s0168-8278(97)80323-6.
BACKGROUND/AIMS: Angiogenesis is critical for the development and progression of solid tumors. The purpose of this study was to evaluate the possible role of vascular endothelial growth factor (which is considered to be one of the most important factors involved in tumor-associated angiogenesis), in human hepatocellular carcinoma.
Vascular endothelial growth factor gene and protein expression were analyzed by means of Northern hybridization and immunohistochemical methods in 5 hepatocellular carcinoma cell lines. Secretion of vascular endothelial growth factor was evaluated by immunoblotting of conditioned medium of these hepatocellular carcinoma cells. Further, we compared the level of vascular endothelial growth factor expression in hepatocellular carcinoma tissues along with that in surrounding tumor-free tissues obtained from 20 patients. We also analyzed mRNA expression of Flt-1, one of the vascular endothelial growth factor specific high-affinity receptors, in hepatocellular carcinoma cell lines.
Northern hybridization analysis and immunohistochemistry revealed that all cultured hepatocellular carcinoma cells exhibited a high level of vascular endothelial growth factor mRNA. In addition, vascular endothelial growth factor secretion by Hep G2, one of the hepatocellular carcinoma cell lines, was shown by Western blot. In vivo, we observed vascular endothelial growth factor expression in both hepatocellular carcinoma and non-hepatocellular carcinoma tissues. However, in 12 of 20 cases, vascular endothelial growth factor mRNA levels were significantly up-regulated in hepatocellular carcinoma tissues. In the majority of cases (10 out of 12 cases) with abundant tumor vascularity, vascular endothelial growth factor mRNA up-regulation in hepatocellular carcinoma tissues was observed. We failed to detect Flt-1 mRNA expression in hepatocellular carcinoma cells.
This study suggests that the possibility that hepatocellular carcinoma cells overexpress the vascular endothelial growth factor gene and protein. These findings support the hypothesis that vascular endothelial growth factor is one of the important factors involved in the angiogenesis of hepatocellular carcinoma, and may even be involved in the development and/or progression of hepatocellular carcinoma itself.
背景/目的:血管生成对于实体瘤的发展和进展至关重要。本研究的目的是评估血管内皮生长因子(被认为是肿瘤相关血管生成中最重要的因素之一)在人类肝细胞癌中的可能作用。
采用Northern杂交和免疫组化方法分析了5种肝癌细胞系中血管内皮生长因子基因和蛋白的表达。通过对这些肝癌细胞条件培养基的免疫印迹评估血管内皮生长因子的分泌。此外,我们比较了20例患者肝癌组织及其周围无肿瘤组织中血管内皮生长因子的表达水平。我们还分析了肝癌细胞系中血管内皮生长因子特异性高亲和力受体之一Flt-1的mRNA表达。
Northern杂交分析和免疫组化显示,所有培养的肝癌细胞均表现出高水平的血管内皮生长因子mRNA。此外,Western印迹显示肝癌细胞系之一Hep G2分泌血管内皮生长因子。在体内,我们在肝癌组织和非肝癌组织中均观察到血管内皮生长因子的表达。然而,在20例中的12例中,肝癌组织中血管内皮生长因子mRNA水平显著上调。在大多数肿瘤血管丰富的病例(12例中的10例)中,观察到肝癌组织中血管内皮生长因子mRNA上调。我们未能在肝癌细胞中检测到Flt-1 mRNA表达。
本研究提示肝癌细胞有过表达血管内皮生长因子基因和蛋白的可能性。这些发现支持了血管内皮生长因子是参与肝癌血管生成的重要因素之一,甚至可能参与肝癌自身发展和/或进展的假说。